There is evidence that chemical exposure during development can cause irreversible impairments of the human developing nervous system. Therefore, testing compounds for their developmentally neurotoxic potential has high priority for different stakeholders: academia, industry, and regulatory bodies. Due to the resource-intensity of current developmental neurotoxicity (DNT) in vivo guidelines, alternative methods that are scientifically valid and have a high predictivity for humans are especially desired by regulators. Here, we review availability of stemÀ/progenitor cell-based in vitro methods for DNT evaluation that is based on the concept of neurodevelopmental process assessment. These test methods are assembled into a DNT in vitro testing battery. Gaps in this testing battery addressing research needs are also pointed out.
There is evidence that chemical exposure during development can cause irreversible impairments of the human developing nervous system (Andersen et al., 2000; Bearer, 2001; Claudio, 2001; Landrigan, 2006, 2014; Mendola et al., 2002; Rodier, 1995; Slikker, 1994) . Neurological damage ranging from subtle to severe imposes significant burdens on affected individuals, their families, and society (Goldman and Koduru, 2000; Weiss and Lambert, 2000) . Therefore, testing compounds for their developmentally neurotoxic potential has high priority for different stakeholders: academia, industry, and regulatory bodies (Bal-Price et al., 2015; Crofton et al., 2014; Fritsche et al., , 2018 . Due to the resource intensity of current DNT in vivo guidelines, alternative methods that are scientifically valid and have a high predictivity for humans are especially desired by regulators Crofton et al., 2011; Fritsche et al., , 2018 Lein et al., 2005) .
Development of these alternative methods are based on the strategy that the complex procedure of brain development is disassembled into spatiotemporal neurodevelopmental processes that are necessary for forming a brain. According to the adverse outcome pathway concept, such are key events for DNT that can be tested for adverse effects of compounds in in vitro assays (Bal-Price et al., 2015 . To avoid species differences in responses to compound exposure (Baumann et al., 2016; Dach et al., 2017; Gassmann et al., 2010; Harrill et al., 2011a; Masjosthusmann et al., 2018) , key eventrelated DNT evaluation is preferably using human cells, ie, neural stem/progenitor cells (NS/PC) including human-induced pluripotent stem cell (hiPSC)-derived NPC as a source (Bal-Price et al., 2018b; Singh et al., 2016) . In this article, we will summarize the current state of the art on NS/PC-based methods for evaluation of neurodevelopmental toxicity. DNT methods published until April 2014 were assembled in a systematic review earlier .
ESC DIFFERENTIATION TO NEUROEPITHELIAL PRECURSORS (NEP)/INDUCTION OF NEURONAL ROSETTES
Tests for studying compound effects on the early neurodevelopmental endpoint stem cell differentiation to NEP based on human embryonic stem cells (hESC) were developed (summarized in Fritsche et al., 2015; Shinde et al., 2015; Waldmann et al., 2014) . Here, rosette morphology and/or gene expression and viability are measured. In addition, a teratogenicity index was developed as a test method for distinguishing between DNT-specific and cytotoxic compound effects that promotes performing transcriptomebased DNT studies at noncytotoxic concentrations (Waldmann et al., 2014) . In a recent work, disturbance of neural rosette formation from hESC was studied in the context of toxicant-dependent altered DNA methylation (Du et al., 2018) . Similar to hESC, hiPSC also form neural rosettes that further mature to neurons when injected into mouse motorcortex (Malchenko et al., 2014) .
NPC PROLIFERATION
Proliferation of neural progenitor cells determines brain size (de Groot et al., 2005) . Different cell systems are available to study effects on proliferation in vitro: hESC-generated NPC, primary hNPC, hiPSC-derived NPC, the human umbilical cord blood (hUCB)-NSC line or ReNcell CX-based systems assessing proliferation in two-dimensional (2D) cultures with the bromodeoxyuridine (BrdU) or ethynyldeoxyuridine (EdU) assay that quantifies incorporation of the thymidine analogue BrdU or EdU into the DNA via fluorescence or luminescence-labeled antibodies, or by quantifying Ki67 expression. A variety of groups used hESC-based methods for studying the effects of single (summarized in Fritsche et al., 2015; Sohn et al., 2017; Wang et al., 2016) or multiple (Behl et al., 2015; Radio et al., 2015) compounds on NPC proliferation. Lately, the frequency of cell cycles per day was calculated from the number of hESC-NSC, which was counted daily using a Neubauer hemocytometer (Vichier-Guerre et al., 2017) . While this is a cheap and easy method, it has a high variability and needs verification by an additional established method like the BrdU assay.
Also, 3D NPC aggregates generated from primary human material (Lonza, Belgium; NPC1 Assay; Bal-Price et al., 2018a) or from hiPSC (Hofrichter et al., 2017) called neurospheres are used for assessing compound effects on NPC proliferation. Here, the diameter increase of individual spheres over time or BrdU incorporation are two different ways of measuring cell replication (Baumann et al., , 2016 Fritsche et al., 2015) . The increase in sphere diameter over time of single spheres plated in wells of a 96-well plate is a fast and cheap possibly first tier screening method for analyzing cell proliferation.
NPC APOPTOSIS
Apoptosis is a well-balanced process during brain development with alterations in both directions, increase or decrease, having negative implications for organ development (Hakem et al., 1998; Uzquiano et al., 2018) . It can be measured by different methods in vitro ranging from early events like mitochondria calcium or cytochrome c release or annexin V presentation, intermediate processes like caspase activation or late apoptotic activities like nuclear condensation, micronucleus formation, or chromatin disintegration. Several stem cell-based cell systems are suitable for detection of xenobiotic-induced apoptosis, ie, hESC-NPC and ReNcell CX culture, primary hNPC growing as monolayers in 2D, or as neurospheres in 3D (summarized in Fritsche et al., 2015) . Lately, the neurosphere system was used for studying the effects of gestational age and sex on methylmercury-induced apoptosis by quantification of condensed nuclei (Edoff et al., 2017) . With the ReNcell CX culture, a high content imaging analysis (HCA) assay based on multiplexed activated caspase-3/-7 (apoptosis) and protease (viability) activities. This method was applied to a comparative study of mouse cortical NPC (Millipore, Temecula, CA), immortalized NPC (ReNcell CX, Millipore), hESC-derived NSC (ArunA Biomedical, Athens, GA), and hiPSC-derived pure neuronal cultures (iCell, Cellular Dynamics International, Madison, WI) using 12 positive and negative compounds impressively demonstrating different susceptibilities toward compoundinduced apoptosis between species and between brain cells of different developmental stages (Druwe et al., 2015) . Another comparative study assessed caspase-3/-7 activation by multiple compounds in a 384-well format using primary hNPC growing as monolayers (ThermoFisher, Waltham, Massachusetts), the neuroblastoma cell line SH-SY5Y, and the immortalized fetal mesencephalic cell line LUHMES. These different cell types show different sensitivities toward compound-induced caspase-3/-7 activation (Tong et al., 2017) . A different commercial hNPC source are ENStem-ATM hNPCs (ArunA Biomedical, Athens, Georgia). These cells growing in monolayers were used for multiplexed imaging analyses of live/dead/apoptotic cells by calcein AM/PI stainings in 96-well plates .
RADIAL GLIA PROLIFERATION
The multitudes of radial glia cell types play diverse key roles during cerebral cortex development (Gotz and Huttner, 2005; Uzquiano et al., 2018) . Stem cell-based in vitro methods for studying compound effects on radial glia are sparse. Primary hNPC (Lonza, Verviers, Belgium) growing as neurospheres is one cell system producing migrating, nestinþ/GFAPþ cells that have radial glia-like morphology after 24 h in differentiation culture ( Figure 1 ; Bal-Price et al., 2018a). These differentiated hNPC express a variety of radial glia cell markers and respond to bone morphogenic protein (BMP)2 with increased astrocyte differentiation (Masjosthusmann et al., 2018) . Radial glia can also be differentiated from rosette-forming hESC or hiPSC (Malchenko et al., 2014) .
MIGRATION OF NEURAL CREST CELLS (NCC)/ RADIAL GLIA/NEURONS
Different neural cell types need proper migration during development. During embryogenesis, NCC migrate to distinct parts of the embryo developing into a variety of extracerebral cells and tissues causing diseases like cleft palate, hearing loss, Morbus Hirschsprung, or CHARGE syndrome when defective (Dupin and Sommer, 2012; Mayor and Theveneau, 2013) . NCC migration can be studied with an in vitro assay, the "MINC Assay", based on neural crest cells (NCC) that are differentiated from hESC (Zimmer et al., 2012) . There are two different ways to perform the MINC Assay: the scratch method (Dreser et al., 2015; Pallocca et al., 2016; Zimmer et al., 2012 Zimmer et al., , 2014 or the recently developed stamp method (Nyffeler et al., 2017) with the latter being more robust.
Cortex development involves radial glia migration leading to the development of a scaffold that is subsequently used by neurons to migrate along these glial fibers and reach their final cortical destination (Borrell and Gotz, 2014) . One well-characterized migration assay is part of the "Neurosphere Assay" (NPC2; BalPrice et al., 2018a). Migration distance that cells cover by radially migrating out of the plated neurosphere is analyzed either manually using programs like ImageJ (Bal-Price et al., 2018a; Barenys et al., 2017; Baumann et al., 2015 Baumann et al., , 2016 Edoff et al., 2017; Fritsche et al., 2015; Ivanov et al., 2016) or by HCA using the software "Omnisphero" . An important issue when evaluating effects of compounds on NPC migration with the 'Neurosphere Assay' is to distinguish between specific effects on migration and secondary migration effects due to cytotoxicity. Our recent data shows that migration distance or pattern, which determines the size of the total migration area, defines the magnitude of signal of viability assays like the Cell Titer Blue Assay (CTB Assay; Promega) because it is related to cell number. A different viability/cytotoxicity assay measuring a readout not directly dependent on cell number, like LDH leakage, indicates the specific effects of methylmercury (MeHgCl) on migration without producing cell death at two different time points ( Figs. 2A and 2B) . Similarly, epigallocatechin gallate (EGCG) inhibits adhesion and migration of hNPC thereby changing the migration pattern and area ( Figure 2C ; Bal-Price et al., 2017; Barenys et al., 2017) . After 3 days of migration in the presence of EGCG, the CTB assay suggests that EGCG reduces cell viability ( Figure 2D ). However, FACS analyses identifying annexin V-/PI-positive cells clearly show that EGCG does not cause cell death, but diminishes the cell area with access to the CTB substrate ( Figure 2E ).
Migrated cells of the NPC2 assay form a 2-layered cell layer with neurons migrating on top of the glia cells (Al ep ee et al., 2014; Baumann et al., 2016) . This enables measuring not only glia cell migration, but also the neuronal migration by assessing individual neuronal positions using the software Ominsphero . Hence, NPC2 can be utilized to assess radial glia and neuronal migration at the same time.
Migration analyses can also be performed with hiPSCderived NPC (hiNPC2; Hofrichter et al., 2017) . Migration distance is similar between NPC2 and hiNPC. Yet, the first cells migrating from the hiNPC neurosphere are neurons and not radial glia as from the hNPC sphere.
ASTROCYTE DIFFERENTIATION/MATURATION
Astroglia differentiation is a crucial event during brain development because astrocytes obtain a variety of central functions in brain (Kettenmann and Verkhratsky, 2011) . Astrocyte differentiation can be measured in developing mixed cell cultures by counting the percentage of, eg, GFAPþ or vimentinþ cells from the total number of differentiated hESC, primary hNPC or hUCB-NSC (summarized in Fritsche et al., 2015; Edoff et al., 2017) . Lately, also hiPSC differentiation into the astrocyte lineage was employed in a toxicological context either in 2D (after 28 days) or in 3D (after 56 days) by creating "brain balls" in shaking cultures (Pamies et al., 2017 (Pamies et al., , 2018b Pistollato et al., 2014) . Moreover, morphogen-induced astrocyte maturation can be studied in the context of the "Neurosphere assay" (Masjosthusmann et al., 2018) . Apart from toxicology, clearly more data on astrocyte differentiation is available on the basic science level, which is summarized, eg, in Chandrasekaran et al. (2016) . Astrocyte function as the most relevant readout was recently compared between long-term self-renewing hiPSC-derived neuroepithelial-like stem cells (ltNES; Falk et al., 2012)-astrocytes, human primary adult astrocytes (phaAstro), an astrocytoma cell line CCF-STTG1 (CCF), and hiPSC-derived astrocytes from Cellular Dynamics International (iCellAstro). Here, ltNESastrocytes were the only ones expressing functional, glutamate transporting SLC1A3 protein, which is an assay suitable for higher throughput drug screening (Lundin et al., 2018) .
OLIGODENDROCYTE DIFFERENTIATION/ MATURATION
Oligodendrogenesis is necessary for proper brain functioning as oligodendrocytes form and keep myelin sheaths around axons (Baumann and Pham-Dinh, 2001 ). Data on chemical effects on hESC-, hNPC-, or hUCB-NSC-derived oligodendrocytes are summarized in Fritsche et al. (2015) . Different groups have recently established further oligodendrocyte differentiation protocols using hESC/hiPSC growing feeder-free (Douvaras et al., 2014; Gorris et al., 2015; Madill et al., 2016; Yamashita et al., 2017) to study differentiation of oligodendrocytes in a toxicological context. Oligodendrocytes emerge late during nervous system development and differentiation of hESC/hiPSC into the oligodendrocyte lineage following the above-mentioned protocols needs several weeks making medium-to-high throughput screening for oligodendrocyte toxicity using hESC/hiPSC a great challenge. In contrast, oligodendrocyte formation and maturation can be studied with hNPC growing as neurospheres with the NPC5/6 assay within a neurosphere differentiation time of 5 days (Figure 3 ; Bal-Price et al., 2018a; Dach et al., 2017) . These assays are based on manual or automated oligodendrocyte quantification as a measure for oligodendrocyte formation (NPC5; Figure 3 ; Bal-Price et al., 2018a; Barenys et al., 2017) , which is the normalization basis for subsequent thyroid hormone (TH)-dependent myelin basic protein (MBP) expression as a measure for oligodendrocyte maturation (Bal-Price et al., 2018a; Dach et al., 2017) . Interference of a compound with the THinduced oligodendrocyte maturation is thus an assay for identifying TH disruptors (NPC6). Oligodendrocyte precursor cells can also be enriched by isolation from gestational week 10-13 fetal human neurospheres (Lu et al., 2015) .
NEUROGENESIS
Neurogenesis is one of the most frequently studied endpoints for DNT evaluation. Compounds' effects on neuronal differentiation have been studied in hESC-(summarized in Ehashi et al. Kashyap et al., 2015; Zychowicz et al., 2014) cultures in 2D, as well as in hiPSC-derived mixed-culture "brain balls" in 3D (Pamies et al., 2017) and hiPSC-generated (Hofrichter et al., 2017) or primary neurospheres (summarized in Fritsche et al., 2015 and Bal-Price et al., 2018a; Masjosthusmann et al., 2018) differentiating in "secondary 3D" structures. Within some of the abovementioned studies, differences in sensitivity and specificity of DNT effects between neuronal cells toward methylmercury were observed. These are probably due to the large differences in stem cell cultivation and differentiation protocols concerning, eg, medium, feeder cell status, timing, differentiation through hESC-derived NPC or direct neuronal differentiation, amounts of glia present and level of quality control, just to mention some. Especially quality control and reporting standards are a large issue in current stem cell work that urgently need standardization as recently voiced by a workshop report on "Advanced good cell culture practice for human primary, stem cell-derived and organoid models' (Pamies et al., 2018a) .
Concerning cell-type composition, mixed neuron-glia cultures are advantageous for DNT testing as different cell types might have different susceptibilities toward compounds (Pei et al., 2016) , eg, astroglia might alter developmental toxicity to neurons (Wu et al., 2017) . In addition, the advantage of the monolayer differentiation protocols clearly lie in the more simple evaluation, eg, by high content image analyses (HCA), whereas the 3D differentiated methods are more complex to evaluate via immunostainings. Somewhat in-between are neurosphere-based methods that differentiate in so-called "secondary 3D" structures, ie, maintaining the multicellular organism aspect (Masjosthusmann et al., 2018) despite plating of spheres on a 2D surface (Al ep ee et al., 2014).
NEURONAL MATURATION
Dendritic and axonal (neurite) outgrowth followed by the formation of synapses are key cellular features associated with the functional maturation of the CNS. Neurite morphology can be measured with a variety of methods including neurite number, length, branching, or area using HCA, a fairly reliable and suitable image-based method for higher throughput applications (Harrill et material for such analyses includes hESC-derived almost pure neuronal cultures (hN2TM, ArunA Biomedical Inc., Athens, Georgia; Behl et al., 2015; Harrill et al., 2011a; Wilson et al., 2014) that were treated after neuronal specification had already taken place; hESC-derived hNP cells (hNP1 TM 00001, ArunA Biomedical Inc.) treated when cells were making the transition from proliferating NPC to postmitotic neurons (Wang et al., 2016) ; hESCderived hNPC (Chemicon-Millipore Norcross, Georgia; Zeng et al., 2016); 3D aggregated hESC-derived embryoid bodies (He et al., 2012) ; hiPSC-generated iCell neurons (Cellular Dynamics International; Ryan et al., 2016) ; hiPSC-derived hNPC growing as neurospheres (Hofrichter et al., 2017) ; primary NPC differentiating into mixed cultures (NPC4; Bal-Price et al., 2018a; Edoff et al., 2017; Schmuck et al., 2017) , ie, multiple parameters of the neurosphere assay including neurite morphology can be assessed with the algorithm Omnisphero (www.omnisphero.com; last accessed July 2018; Schmuck et al., 2017) ; or LUHMES cells (Krug et al., 2013; Scholz et al., 2011) .
NEURONAL SUBTYPE DIFFERENTIATION
During brain development, neural stem and progenitor cells produce a variety of neuronal subtypes, which differentiate at different stages and in different regions of the brain. Compounds' effects on neuronal subtype differentiation has mostly been assessed for dopaminergic (DA) neurons using hESC (Huang et al., 2017; Stummann et al., 2009; Zeng et al., 2006) , for DA as well as cholinergic neurons using hUCB-NSC (Kashyap et al., 2015) and for DA, glutamate-and GABAergic neurons employing hiPSC (Pistollato et al., 2017) .
SYNAPTOGENESIS/NEURONAL NETWORK FORMATION
During early neurogenesis neurons start to mature, become electrically active and connect via synapses (Okado et al., 1979; Zecevic and Antic, 1998) . For the function of the CNS this neuronal maturation and the formation of synapses is crucial. So far, DNT testing for synaptogenesis and neuronal activity in the developing brain has mainly been performed using rat primary cells (Harrill et al., 2011b; Hogberg et al., 2011; Robinette et al., 2011) and no in vitro DNT study has been published using hESC or hiPSC for assessing compound effects on neuronal network activity. However, there are a number of promising systems under development that have been used for acute neurotoxicity evaluations studying either synaptogenesis and/or neuronal electrical activity including hESC (Kapucu et al., 2012; Oh et al., 2016; Sandströ m et al., 2017; Yla-Outinen et al., 2010) or hiPSC neuronal network differentiation methods (Figure 3 ; Hofrichter et al., 2017; Pellett et al., 2015; Pistollato et al., 2017; Toivonen et al., 2013) . Here, the use of hiPSC-derived neuronal networks growing directly on microelectrode arrays (MEAs) seems to be a promising method for screening neurodevelopmental toxins for their adverse effects on neuronal network formation. What are the difficulties one faces with stem cell-based active neuronal networks for DNT evaluation? Every single neuronal network differentiates into a variable amount of neurons, ie, variable neuron/glia ratio, as well as neuronal subtypes that form neuronal connections by chance. Therefore, each network exhibits its own baseline activity level with high MEA-to-MEA variability making comparison of developmentally exposed neuronal networks to control networks very difficult. In Figure 4 . hNPC growing as neurospheres in proliferation culture, were plated for migration analyses onto poly D-lysin/laminin-coated glass slides in presence and absence of MeHgCl. After (A) 24 and (B) 72 h, migration distance was measured from the outer sphere rim to the furthest migrated cells at four opposite positions. Cell titer blue (CTB) and lactate dehydrogenase (LDH) assays were performed as described previously (Baumann et al. 2014) . C, Neurospheres were plated as described in (A) in presence and absence of epigallocathechin gallate (EGCG). After 24 h the migration area was analyzed visually by phase contrast microscopy and for better visualization images were subjected to a black/white filter. D, Viability analyses using the CTB assay were performed on each day up to 5 DIV. E, On day 5, FACS analyses of dissociated hNPC were performed after annexin V/PI staining. As a positive control, spheres were treated with the topoisomerase I inhibitor camptothecin. addition, network activity is generally not very high compared with rodent networks. Developing rat networks differentiate faster and show much higher activity levels and synchronization than stem cell-based human networks. This makes analyses of the adverse effects of toxicants on human networks much more difficult. To overcome these restrictions and make neuronal human stem cell-based networks more standardized and reproducible, one can envision making use of the relatively new method of 3D bioprinting (Zhuang et al., 2018) . Using this method, neural cells might directly be printed in a threedimensional hydrogel precisely on MEAs (Tedesco et al., 2018) .
SUMMARY AND CONCLUSION
During the last 15 years, much effort has been put into establishment, scientific validation, and test method set up for DNT in vitro evaluation. In addition to primary rodent cultures, which are valuable cell methods for comparing compounds' effects in vivo to in vitro, stem/progenitor cell-based methods have become available that can now be assembled into a DNT in vitro testing battery (summarized in Bal-Price et al., 2018a). Such a testing battery is necessary for covering the immense complexity of neurodevelopmental processes as well as timing aspects of brain development. However, the current state of the science concerning the testing battery is probably still at an early, immature state. While a variety of important key events are very well covered in the strategy, ie, neural proliferation, apoptosis, NPC migration, neuronal differentiation and neurite morphology, there are also some crucial aspects less well covered. These include glia differentiation and maturation, glia cell function, neuronal maturation, and neuronal network formation with assessment of electrical network activity. Moreover, the complexity of brain region-specific neural differentiation and function has not been addressed in DNT assays yet. However, basic science is moving down this path by creating brain region-specific organoids (Lancaster et al., 2013; Qian et al., 2016) that might be suited for studying region-specific effects of compounds on neurodevelopmental key events. In addition, hormone-related DNT has only been touched marginally with stem cell-based human DNT in vitro assays by studying interference with cellular thyroid hormone or glucocorticoid signaling (Moors et al., 2012) . Hormonal contributions to brain development are much more manifold and complex and chemicals with endocrine activities are thus suspected to interfere with neurodevelopment (WHO-UNEP, 2012). Here, interference with estrogen, androgen, retinoid, progesterone, peroxysome proliferator-activated receptor, or endocannabinoid signaling pathways might have implications for the developing brain at specific developmental stages. Especially sex hormone-related cellular and organ function is crucial for the development of gender-specific behavior, which follows species-specific traits (Wallen and Baum, 2002) . Molecular aspects of the development of such human sex-specific behavior is an understudied field of research posing a challenge for in vitro DNT evaluation. Yet, primary human cells show some sex-specific neurodevelopmental key event response differences toward methylmercury (Edoff et al., 2017) without understanding the mechanistic implications behind these observations yet. Attempts are made to tackle this issue with rodent in vitro methods . In this line, the largest challenge will be the understanding of disturbance of emotional and intellectual consciousness by chemical exposure in humans. Understanding physiology behind these human traits is a prerequisite that might enable establishment of adverse outcome pathways for these fundamental human aspects in the future. 
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